Article

Marcelo V. Netto named Troutman Award recipient

Marcelo V. Netto, MD, received the annual Troutman Award this year for his paper describing the findings from wavefront analysis in a population of normal refractive surgery patients.

Marcelo V. Netto, MD, received the annual Troutman Award this year for his paper describing the findings from wavefront analysis in a population of normal refractive surgery patients.

Established by Richard Troutman, MD, 15 years ago, the Troutman Award is given to the lead author of an outstanding article in the Journal of Refractive Surgery. Candidates are under 45 years of age and a member of the American Academy of Ophthalmology and the International Society of Refractive Surgery.

Introducing Dr. Netto, George O. Waring III, MD, noted his paper establishing normative population statistics was recognized for its contribution as important fundamental research.

Dr. Netto is currently in the cornea and refractive surgery department, University of Sao Paulo, Brazil. He conducted the study as a fellow at the Cole Eye Institute, Cleveland Clinic Foundation. Using the WaveScan WavePrint system (VISX), Dr. Netto and colleagues measured aberrations in 418 eyes of 226 consecutive refractive surgery patients. The study population had a mean age of about 43 years, included a slight majority of men (53%), and had a mean SE of -3.4D

The results showed that while defocus and astigmatism were the predominant aberrations in these patients, the surgical candidates had significant amounts of higher-order aberrations increased with increasing pupil size and patient age, but it was unrelated to patient gender.

"It was clear from this study that these higher-order aberrations could underlie visual complaints in patients who had 20/20 or better uncorrected Snellen acuity," Dr. Netto said.

"Wavefront technology has changed our understanding of visual optics, and using that information to guide customized ablations we are achieving excellent results with all laser platforms," he said. "In the future, we might expect even better outcomes with increased understanding of ocular aberrations along with corneal biomechanics and wound healing. However, we will need visual function tests other than high-contrast Snellen acuity to demonstrate its major benefits."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.